Bruce I. Sachs's most recent trade in Vertex Pharmaceuticals, Inc. was a trade of 3,366 Common Stock done at an average price of $389.8 . Disclosure was reported to the exchange on Aug. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharma | Bruce I. Sachs | Director | Purchase of securities on an exchange or from another person at price $ 389.84 per share. | 06 Aug 2025 | 3,366 | 45,000 (0%) | 0% | 389.8 | 1,312,201 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Purchase of securities on an exchange or from another person at price $ 389.36 per share. | 06 Aug 2025 | 1,634 | 41,634 (0%) | 0% | 389.4 | 636,214 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 101 | 15,341 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 2,398 | 2,398 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 95 | 15,240 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 111 | 15,144 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2024 | 90 | 15,033 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 5,295 | 0 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Sale of securities on an exchange or to another person at price $ 508.00 per share. | 01 Aug 2024 | 5,295 | 40,000 (0%) | 0% | 508 | 2,689,860 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 125.71 per share. | 01 Aug 2024 | 5,295 | 45,295 (0%) | 0% | 125.7 | 665,634 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 89 | 14,943 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 7,073 | 0 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Sale of securities on an exchange or to another person at price $ 448.00 per share. | 22 May 2024 | 7,073 | 40,000 (0%) | 0% | 448 | 3,168,704 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.51 per share. | 22 May 2024 | 7,073 | 47,073 (0%) | 0% | 93.5 | 661,396 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,142 | 3,142 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2024 | 109 | 14,853 | - | - | Deferred Stock Units | |
| Vertex Pharma | Sachs Bruce I. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 101 | 14,744 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jul 2023 | 11,250 | 11,250 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 127.54 per share. | 14 Jul 2023 | 11,250 | 51,250 (0%) | 0% | 127.5 | 1,434,825 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Sale of securities on an exchange or to another person at price $ 356.75 per share. | 14 Jul 2023 | 5,711 | 43,842 (0%) | 0% | 356.7 | 2,037,399 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Sale of securities on an exchange or to another person at price $ 357.29 per share. | 14 Jul 2023 | 3,842 | 40,000 (0%) | 0% | 357.3 | 1,372,708 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Sale of securities on an exchange or to another person at price $ 355.54 per share. | 14 Jul 2023 | 1,697 | 49,553 (0%) | 0% | 355.5 | 603,351 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 124 | 14,524 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2023 | 3,481 | 3,481 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 131 | 14,400 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Apr 2023 | 21,300 | 0 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.14 per share. | 12 Apr 2023 | 21,300 | 62,510 (0%) | 0% | 72.1 | 1,536,582 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Sale of securities on an exchange or to another person at price $ 326.46 per share. | 12 Apr 2023 | 10,357 | 49,236 (0%) | 0% | 326.5 | 3,381,146 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Sale of securities on an exchange or to another person at price $ 327.48 per share. | 12 Apr 2023 | 8,026 | 41,210 (0%) | 0% | 327.5 | 2,628,354 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Sale of securities on an exchange or to another person at price $ 325.65 per share. | 12 Apr 2023 | 2,917 | 59,593 (0%) | 0% | 325.6 | 949,921 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Apr 2023 | 1,210 | 40,000 (0%) | 0% | 0 | Common Stock | |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 72.14 per share. | 31 Jan 2023 | 1,200 | 42,410 (0%) | 0% | 72.1 | 86,568 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2023 | 1,200 | 21,300 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Sale of securities on an exchange or to another person at price $ 325.01 per share. | 31 Jan 2023 | 1,200 | 41,210 (0%) | 0% | 325.0 | 390,012 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 146 | 14,268 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2022 | 147 | 14,122 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 151 | 13,974 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2022 | 4,462 | 4,462 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 151 | 13,823 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 189 | 13,672 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 240 | 13,482 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Purchase of securities on an exchange or from another person at price $ 197.91 per share. | 02 Aug 2021 | 15,000 | 41,210 (0%) | 0% | 197.9 | 2,968,650 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2021 | 220 | 13,242 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2021 | 6,067 | 6,067 | - | - | Stock Option (Right to Buy) | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2021 | 198 | 13,021 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 193 | 12,822 | - | - | Deferred Stock Units | |
| Vertex Pharma | Bruce I. Sachs | Director | Purchase of securities on an exchange or from another person at price $ 216.47 per share. | 10 Nov 2020 | 6,825 | 18,035 (0%) | 0% | 216.5 | 1,477,408 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Purchase of securities on an exchange or from another person at price $ 217.49 per share. | 10 Nov 2020 | 4,270 | 22,305 (0%) | 0% | 217.5 | 928,682 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Purchase of securities on an exchange or from another person at price $ 218.79 per share. | 10 Nov 2020 | 3,905 | 26,210 (0%) | 0% | 218.8 | 854,375 | Common Stock |
| Vertex Pharma | Bruce I. Sachs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2020 | 196 | 12,629 | - | - | Deferred Stock Units |